Bill Steinkrauss

Bill Steinkrauss is an experienced finance professional currently serving as President of OWL CFO Consulting, where fractional CFO services are provided to growing biotechnology companies. Bill holds the position of Chief Financial Officer at ILiAD Biotechnologies, LLC and OcuTerra Therapeutics, along with serving as the Interim Chief Financial Officer at PureTech Health. Additionally, Bill is a Board Member at COMPASS and has held significant roles at Curis as Chief Financial Officer and Chief Administrative Officer, as well as Director of Finance at OvaScience. Prior experience includes senior roles in technical accounting at Cubist Pharmaceuticals and a managerial position at PwC, focusing on capital markets and accounting advisory services. Bill earned a Bachelor of Science in Finance and Accounting and a Master of Science in Accounting from Boston College.